Physician profile
Jacob Cohen
NPI 1871527432
$2,053.25
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $26.71 · 2021: $346 · 2022: $452 · 2023: $571 · 2024: $170 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $569.29 | 2019-2025 | Erleada |
| Stryker Corporation | $260.45 | 2023 | Mako |
| Boston Scientific Corporation | $198.48 | 2019-2025 | Ams 700 |
| Southern Edge Orthopaedics, INC. | $154.37 | 2023 | |
| Coloplast Corp | $145.54 | 2019-2023 | Titan |
| Ethicon US, LLC | $112.64 | 2022 | |
| Abbott Laboratories | $110.04 | 2024 | Amplatzer Amulet |
| Medical Device Business Services, INC. | $107.33 | 2019 | |
| Pfizer INC. | $97.52 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $66.24 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $60.00 | 2024 | Affixus |
| Merck Sharp & Dohme LLC | $41.16 | 2021-2022 | |
| Endo USA, INC. | $33.73 | 2025 | Xiaflex |
| Acell, INC. | $33.20 | 2019 | |
| Endo Pharmaceuticals INC. | $23.87 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.67 | 2019 | |
| Myovant Sciences INC. | $17.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.